Stockscreener 앱 받기
1.03
6.69%
0.0646
시간 외 거래:
1.03
전일 마감가:
$0.9654
열려 있는:
$0.99
하루 거래량:
157.80K
Relative Volume:
0.98
시가총액:
$20.15M
수익:
$411.00K
순이익/손실:
$-4.85M
주가수익비율:
-2.3409
EPS:
-0.44
순현금흐름:
$-4.88M
1주 성능:
+17.01%
1개월 성능:
+17.05%
6개월 성능:
-25.36%
1년 성능:
-68.79%
1일 변동 폭
$0.9502
$1.0499
1주일 범위
$0.8571
$1.0499
52주 변동 폭
$0.7749
$3.72
Lexaria Bioscience Corp Stock (LEXX) Company Profile
명칭
Lexaria Bioscience Corp
전화
250-765-6424
주소
100 - 740 MCCURDY ROAD, KELOWNA
LEXX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
1.03 | 18.88M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexaria Bioscience Corp 주식(LEXX)의 최신 뉴스
What machine learning models say about Lexaria Bioscience Corp. Equity WarrantQuarterly Profit Summary & Low Risk Entry Point Tips - Newser
What data driven models say about Lexaria Bioscience Corp.’s futureMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - Newser
Can momentum traders help lift Lexaria Bioscience Corp.2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
Multi factor analysis applied to Lexaria Bioscience Corp.July 2025 PostEarnings & Technical Confirmation Alerts - Newser
Applying chart zones and confluence areas to Lexaria Bioscience Corp. Equity WarrantJuly 2025 Intraday Action & Community Consensus Trade Alerts - Newser
When is the best time to exit Lexaria Bioscience Corp. Equity WarrantWeekly Loss Report & Long-Term Capital Growth Strategies - Newser
Should I average down on Lexaria Bioscience Corp. stock2025 Key Lessons & Intraday High Probability Alerts - خودرو بانک
What is Lexaria Bioscience Corp. s revenue forecast2025 Earnings Impact & Short-Term Swing Trade Alerts - خودرو بانک
What analysts say about Lexaria Bioscience Corp. stockGlobal Markets & Trade Opportunity Analysis - خودرو بانک
How does Lexaria Bioscience Corp. score in quality rankings2025 Risk Factors & AI Forecasted Entry/Exit Points - خودرو بانک
What’s the MACD signal for Lexaria Bioscience Corp. Equity WarrantJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - خودرو بانک
Update Recap: Will Lexaria Bioscience Corp. benefit from government policy2025 Big Picture & High Accuracy Swing Entry Alerts - خودرو بانک
Will Lexaria Bioscience Corp. Equity Warrant benefit from geopolitical trendsMarket Sentiment Report & Daily Entry Point Trade Alerts - خودرو بانک
What are Lexaria Bioscience Corp. Equity Warrant’s earnings expectationsJuly 2025 Earnings & Fast Exit and Entry Trade Guides - خودرو بانک
How hedge fund analytics apply to Lexaria Bioscience Corp. Equity Warrant stockEarnings Miss & Daily Technical Stock Forecast Reports - Newser
Will Lexaria Bioscience Corp. benefit from geopolitical trends2025 Top Decliners & AI Based Buy/Sell Signal Reports - خودرو بانک
Sell Signal: Will Lexaria Bioscience Corp. Equity Warrant benefit from geopolitical trendsPortfolio Return Summary & Real-Time Market Sentiment Reports - خودرو بانک
Can Lexaria Bioscience Corp. be recession proofRisk Management & Long-Term Capital Growth Ideas - خودرو بانک
Using R and stats models for Lexaria Bioscience Corp. Equity Warrant forecastingJuly 2025 Short Interest & Risk Controlled Swing Alerts - Newser
Will Lexaria Bioscience Corp. Equity Warrant see short term momentumWeekly Risk Summary & Precise Buy Zone Tips - Newser
Relative strength of Lexaria Bioscience Corp. Equity Warrant in sector analysisQuarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - Newser
What recovery options are there for Lexaria Bioscience Corp.July 2025 Volume & Smart Allocation Stock Reports - Newser
Is Lexaria Bioscience Corp. vulnerable to short sellersEarnings Beat & Daily Profit Focused Screening - خودرو بانک
Pattern recognition hints at Lexaria Bioscience Corp. upsideWeekly Gains Report & Safe Capital Growth Trade Ideas - Newser
Is Lexaria Bioscience Corp. trending in predictive chart modelsTrade Volume Summary & Long-Term Growth Plans - Newser
Can Lexaria Bioscience Corp. Equity Warrant ride the EV waveJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - خودرو بانک
Comparing Lexaria Bioscience Corp. in custom built stock radars2025 Analyst Calls & AI Driven Stock Reports - Newser
Will Lexaria Bioscience Corp. Equity Warrant bounce back from current supportJuly 2025 Catalysts & Reliable Momentum Entry Alerts - Newser
What’s the recovery path for long term holders of Lexaria Bioscience Corp. Equity WarrantTrade Risk Report & Capital Efficiency Focused Ideas - Newser
Using data filters to optimize entry into Lexaria Bioscience Corp. Equity WarrantMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
Will Lexaria Bioscience Corp. Equity Warrant stock go up soonWeekly Gains Summary & Fast Exit and Entry Trade Guides - Newser
How sentiment analysis helps forecast Lexaria Bioscience Corp. Equity WarrantQuarterly Earnings Summary & Detailed Earnings Play Strategies - Newser
Will Lexaria Bioscience Corp. stock recover after earnings2025 Support & Resistance & Real-Time Chart Breakout Alerts - خودرو بانک
Using data models to predict Lexaria Bioscience Corp. Equity Warrant stock movementPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
Can Lexaria Bioscience Corp. be the next market leader2025 Institutional Moves & Community Consensus Stock Picks - خودرو بانک
Is Lexaria Bioscience Corp. Equity Warrant showing signs of accumulationGold Moves & Risk Managed Investment Signals - Newser
Is Lexaria Bioscience Corp. Equity Warrant stock undervalued right now2025 Market WrapUp & Weekly Top Gainers Trade List - خودرو بانک
Using Bollinger Bands to evaluate Lexaria Bioscience Corp.Portfolio Value Summary & Weekly High Momentum Picks - Newser
Is Lexaria Bioscience Corp. a defensive stock2025 Pullback Review & Weekly Return Optimization Alerts - خودرو بانک
Price action breakdown for Lexaria Bioscience Corp.Weekly Earnings Recap & Safe Entry Point Identification - Newser
Detecting price anomalies in Lexaria Bioscience Corp. with AIEarnings Summary Report & Breakout Confirmation Alerts - Newser
Lexaria Bioscience Corp.’s volatility index tracking explainedTrade Risk Report & Risk Controlled Daily Plans - Newser
Full technical analysis of Lexaria Bioscience Corp. stockBuy Signal & Fast Moving Stock Watchlists - Newser
Is Lexaria Bioscience Corp. Equity Warrant forming a bottoming baseInflation Watch & Fast Exit and Entry Strategy Plans - Newser
What institutional flow reveals about Lexaria Bioscience Corp. Equity WarrantGap Down & AI Driven Stock Reports - Newser
Analyzing Lexaria Bioscience Corp. Equity Warrant with multi timeframe chartsEarnings Overview Summary & Consistent Return Strategy Ideas - Newser
Applying chart zones and confluence areas to Lexaria Bioscience Corp.Sell Signal & Capital Efficiency Focused Ideas - Newser
Is Lexaria Bioscience Corp. stock overvalued or fairly pricedWeekly Profit Analysis & Verified Technical Signals - خودرو بانک
Multi asset correlation models including Lexaria Bioscience Corp.Trade Entry Report & Risk Adjusted Swing Trade Ideas - Newser
Real time scanner hits for Lexaria Bioscience Corp. Equity Warrant explained2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser
Key metrics from Lexaria Bioscience Corp. Equity Warrant’s quarterly dataQuarterly Market Summary & Verified Momentum Stock Alerts - Newser
Lexaria Bioscience Corp (LEXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lexaria Bioscience Corp 주식 (LEXX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BUNKA CHRISTOPHER | Director |
Jul 30 '25 |
Buy |
0.91 |
11,900 |
10,866 |
281,912 |
| McKechnie William Edward | Director |
Jul 29 '25 |
Buy |
0.91 |
5,000 |
4,532 |
18,191 |
| DOCHERTY JOHN MARTIN | President & CSO |
Jul 29 '25 |
Buy |
0.93 |
5,376 |
4,989 |
5,376 |
| Carle Vanessa | Secretary |
Jul 29 '25 |
Buy |
0.91 |
750 |
682 |
750 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Jul 29 '25 |
Buy |
0.91 |
15,000 |
13,641 |
65,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 03 '24 |
Buy |
2.47 |
27,172 |
67,175 |
50,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 02 '24 |
Buy |
2.24 |
22,828 |
51,217 |
22,828 |
1.40%
자본화:
|
볼륨(24시간):